Are Peptides coming off of the FDA Category 2 list? A legal breakdown Holt Law Peptides are starting to move back into the conversation., After years of restriction under the FDAs 503A Category 2 list, were now seeing momentum toward re evaluation and potential reintroduction Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law